Toyobo Biologics Inc.
JAPANESE HOME Corporate Profile Description of CMO service Equipment Inquiry
Corporate Profile
Corporate Profiles

Company Name

Toyobo Biologics Inc. (TBI)
Established November 15th, 2001
President Shinichi Teshima, Ph.D.
Capital 100 million yen
Employees 52 (as of October, 2011)
Head Office 2-2-8, Dojima Hama, Kita-ku, Osaka 530-8230, Japan
Katata Plant 2-1-1, Katata, Otsu, Shiga 520-0292, Japan
Tsurura Plant 10-24, Toyo-cho, Tsuruga, Fukui 914-0047, Japan

History of TBI

1948 :

Started research on the processing of waste pulp with yeast
1970 : Started business for diagnostics reagents
1971 : Started business for reagents and equipments for clinical analysis
1979 : Started development of pharmaceuticals
1982 : Started sales of reagents for life science research
1990 : Application for the approval of tPA (Tissue Plasminogen Activator)
Completed Otsu Pharmaceutical Plant, which was certificated in compliance with GMP standard from Japanese Health Authority (KOSEISHO)
1992 : Established Toyobo Gene Analysis Co., Ltd.
1993 : Started CMO business for pharmaceuticals.
2001 : Established PAC Biologics Inc.
2003 : Completed a 4,000L bioreactor for mammalian cell cultivation in PAC Biologics Inc.
2007 : Changed the company name to "Toyobo Biologics Inc." from PAC biologics Inc.
2010 : Toyobo Biologics Inc. merged with Toyobo Gene Analysis Co., Ltd.

Inquiries
Toyobo Biologics Inc. (TBI)
2-2-8, Dojima Hama, Kita-ku, Osaka 530-8230, Japan
Tel: +81-6-6348-3789 Fax: +81-6-6348-3833
E-Mail:info@toyobobiologics.com



PAGE TOP
2007 Copyright Toyobo Biologics Inc. All Rights Reserved.